Brief: Quantum Genomics Signs Strategic Contract With Delpharm
Dec 16 (Reuters) - Quantum Genomics SA ALQGC.PA :
* QUANTUM GENOMICS SIGNS A STRATEGIC CONTRACT WITH DELPHARM
* DEAL FOR MANUFACTURE OF NEXT CLINICAL BATCHES OF
FIRIBASTAT
TABLETS ON AN INDUSTRIAL SCALE
* DEAL FOR ESTABLISHMENT OF PRODUCTION LINES FOR FUTURE
COMMERCIAL BATCHES
Source text for Eikon: ID:nGNXf0njf
Further company coverage: ALQGC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study